Publicaties

Publicaties 2019

Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: A randomised controlled trial.
Bruls YM, de Ligt M, Lindeboom L, Phielix E, Havekes B, Schaart G, Kornips E, Wildberger JE, Hesselink MK, Muoio D, Schrauwen P, Schrauwen-Hinderling VB. 
EBioMedicine. 2019 Nov;49:318-330. doi:10.1016/j.ebiom.2019.10.017.

Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).
van Beek DJ, Nell S, Pieterman CRC, de Herder WW, van de Ven AC, Dekkers OM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD.
J Surg Oncol. 2019 Nov;120(6):966-975. doi: 10.1002/jso.25667.

TSH suppression aggravates arterial inflammation - an (18)F-FDG PET study in thyroid carcinoma patients.
Boswijk E, Sanders KJC, Broeders EPM, de Ligt M, Vijgen GHEJ, Havekes B, Mingels AMA, Wierts R, van Marken Lichtenbelt WD, Schrauwen P, Mottaghy FM, Wildberger JE, Bucerius J. 
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1428-1438. doi: 10.1007/s00259-019-04292-w.

Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.
Boon MR, Hanssen MJW, Brans B, Hülsman CJM, Hoeks J, Nahon KJ, Bakker C, van Klinken JB, Havekes B, Schaart G, Jazet IM, Rensen PCN, van Marken Lichtenbelt WD. 
Diabetologia. 2019 Jan;62(1):112-122. doi:10.1007/s00125-018-4752-6.

RT-CGM in adults with type 1 diabetes improves both glycaemic and patient-reported outcomes, but independent of each other.
Nefs G, Bazelmans E, Marsman D, Snellen N, Tack CJ, de Galan BE.
Diabetes Res Clin Pract. 2019;158:107910. doi: 10.1016/j.diabres.2019.107910.

Checkpointremmer geïnduceerde diabetes mellitus [Checkpoint inhibitor induced diabetes mellitus].
Leentjens J, Bekkink MO, Koot R, Herbschleb KH, de Galan BE.
Ned Tijdschr Geneeskd. 2019;163:D3726.

SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial.
de Wit L, Rademaker D, Voormolen DN, Akerboom BMC, Kiewiet-Kemper RM, Soeters MR, Verwij-Didden MAL, Assouiki F, Schippers DH, Vermeulen MAR, Kuppens SMI, Oosterwerff MM, Zwart JJ, Diekman MJM, Vogelvang TE, Gallas PRJ, Galjaard S, Visser W, Horree N, Klooker TK, Laan R, Heijligenberg R, Huisjes AJM, van Bemmel T, van Meir CA, van den Beld AW, Hermes W, Vidarsdottir S, Veldhuis-Vlug AG, Dullemond RC, Jansen HJ, Sueters M, de Koning EJP, van Laar JOEH, Wouters-van Poppel P, Sanson-van Praag ME, van den Akker ES, Brouwer CB, Hermsen BB, Potter van Loon BJ, van der Heijden OWH, de Galan BE, van Leeuwen M, Wijbenga JAM, de Boer K, van Bon AC, van der Made FW, Eskes SA, Zandstra M, van Houtum WH, Braams-Lisman BAM, Daemen-Gubbels CRGM, Wouters MGAJ, IJzerman RG, Mensing van Charante NA, Zwertbroek R, Bosmans JE, Evers IM, Mol BW, de Valk HW, Groenendaal F, Naaktgeboren CA, Painter RC, deVries JH, Franx A, van Rijn BB.
BMJ Open. 2019;9(8):e029808.

Clinical impact of artifactual hypoglycaemia and its diagnosis at the bedside.
Drenthen LCA, Verheggen RJHM, de Galan BE.
Rheumatology (Oxford). 2019;58(9):1691-1692.

PET imaging during hypoglycaemia to study adipose tissue metabolism.
Boss M, Rooijackers HMM, Buitinga M, Janssen MJR, Arens AIJ, de Geus-Oei LF, Salm LP, de Galan BE, Gotthardt M.
Eur J Clin Invest. 2019;49(7):e13120. doi: 10.1111/eci.13120. Epub 2019 Apr 29.

Elevated brain glutamate levels in type 1 diabetes: correlations with glycaemic control and age of disease onset but not with hypoglycaemia awareness status.
Wiegers EC, Rooijackers HM, van Asten JJA, Tack CJ, Heerschap A, de Galan BE, van der Graaf M.
Diabetologia. 2019;62(6):1065-1073.

Effect of the GLP-1 receptor agonist exenatide on impaired awareness of hypoglycemia in type 1 diabetes; a randomized controlled trial.
van Meijel LA, Rooijackers HM, Tack CJ, de Galan BE.
J Clin Endocrinol Metab. 2019. pii: jc.2019-00087. doi: 10.1210/jc.2019-00087.

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.
Amiel SA, Aschner P, Childs B, Cryer PE, de Galan BE, Frier BM, Gonder-Frederick L, Heller SR, Jones T, Khunti K, Leiter LA, Luo Y, McCrimmon RJ, Pedersen-Bjergaard U, Seaquist ER, Zoungas S for the International Hypoglycaemia Study Group.
Lancet Diabetes Endocrinol. 2019;7(5):385-396. Erratum in: Lancet Diabetes Endocrinol. 2019 Jun;7(6):e18.

Early Detection of Hypoglycemia in Type 1 Diabetes Using Heart Rate Variability Measured by a Wearable Device.
Olde Bekkink M, Koeneman M, de Galan BE, Bredie SJ.
Diabetes Care. 2019;42(4):689-692.

Effect of Dapagliflozin Treatment on the Expression of Renal Sodium Transporters/Channels on High-Fat Diet Diabetic Mice.
Ma C, de Baaij JHF, Millar PJ, Gault VA, de Galan BE, Bindels RJM, Hoenderop JGJ.
Nephron. 2019;142(1):51-60.

Regional Differences in Cell-Mediated Immunity in People With Diabetic Peripheral Neuropathy.
Pickwell K, Geerts M, van Moorsel D, Hilkman D, Kars M, Schaper NC.
Diabet Med 2019 Sep 26; PMID: 31557355; DOI: 10.1111/dme.14143.

The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study.
Foreman YD, Brouwers MCGJ, Berendschot TTJM, van Dongen MCJM, Eussen SJPM, van Greevenbroek MMJ, Henry RMA, Houben AJHM, van der Kallen CJH, Kroon AA, Reesink KD, Schram MT, Schaper NC, Stehouwer CDA.
Cardiovasc Diabetol. 2019 Nov 14;18(1):152.

Relevant patient characteristics for estimating healthcare needs according to healthcare providers and people with type 2 diabetes: a Delphi survey.
Hertroijs DFL, Brouwers MCGJ, Elissen AMJ, Schaper NC, Ruwaard D.
BMC Health Serv Res. 2019 Aug 16;19(1):575.

Patients with aldolase B deficiency are characterized by an increased intrahepatic triglyceride content.
Simons N, Debray FG, Schaper NC, Kooi ME, Feskens EJM, Hollak CEM, Lindeboom L, Koek GH, Bons JAP, Lefeber DJ, Hodson L, Schalkwijk CG, Stehouwer CDA, Cassiman D, Brouwers MC.
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5056-5064

Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease.
Brouwers MCGJ, Simons N, Stehouwer CD, Koek GH, Schaper NC, Isaacs A.
Hepatol Commun 2019: Feb 11;3(4):587-596

Movement disorders and nonmotor neuropsychological symptoms in children and adults with classical galactosemia.
Kuiper A, Grünewald S, Murphy E, Coenen MA, Eggink H, Zutt R, Rubio-Gozalbo ME, Bosch AM, Williams M, Derks TGJ, Lachmann RHL, Brouwers MC, Janssen MCH, Tijssen MA, de Koning TJ
J Inherit Metab Dis. 2019 May;42(3):451-458

Contribution of liver fat to weight loss-induced changes in serum hepatokines: a randomized-controlled trial.
Telgenkamp I, Kusters YHAM, Schalkwijk CG, Houben AJHM, Kooi ME, Lindeboom L, Bons JAP, Schaper NC, Joris PJ, Plat J, Mensink RP, Stehouwer CDA, Brouwers MCGJ.
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2719-2727

Incidence of cardiovascular disease in familial combined hyperlipidemia: A 15-year follow-up study.
Luijten J, van Greevenbroek MMJ, Schaper NC, Meex SJR, van der Steen C, Meijer LJ, de Boer D, de Graaf J, Stehouwer CDA, Brouwers MCGJ.
Atherosclerosis. 2019 Jan;280:1-6.